Management of HSE
The aim of treatment is to shorten the clinical course of disease, prevent complications and prevent the development of disease recurrence. Drug of choice is acyclovir, which is an antiviral substances that selectively inhibit replication of the virus without damaging normal cells by holding a competition with guanoside for viral DNA polymerase. Acyclovir is said to have the effect of minimum follow-up. The drug is excreted through the kidneys and the dosage should be reduced in patients with renal dysfunction.
The aim of treatment is to shorten the clinical course of disease, prevent complications and prevent the development of disease recurrence. Drug of choice is acyclovir, which is an antiviral substances that selectively inhibit replication of the virus without damaging normal cells by holding a competition with guanoside for viral DNA polymerase. Acyclovir is said to have the effect of minimum follow-up. The drug is excreted through the kidneys and the dosage should be reduced in patients with renal dysfunction.